Per DD on the other board: "The new launch is an “authorized generic” from Sanofi, the maker of branded Lovenox. The AG is the exact same product as branded Lovenox except for the packaging and (presumably) a slightly lower price." Yet our "partner" made sure to call it a new entry into the market. SNY launched the AG to weaken MNTA, our partner helps them. Some people think it will weaken our case against Amph. I don't, I think they cheated and that is the question in front of the Judge.